Zeno Biotechnology

Zeno Biotechnology is a Beijing-based synthetic biology company specializing in the development of high-value natural products through advanced fermentation engineering and gene editing technologies. The company utilizes CRISPR-Cas9 to engineer chassis microorganisms, such as Escherichia coli and Saccharomyces cerevisiae, for the industrial-scale production of complex biological molecules. Its lead product is 2'-Fucosyllactose (2'-FL), a critical human milk oligosaccharide (HMO) used in infant formula and medical nutrition to support immune system development and gastrointestinal health. Zeno Biotechnology focuses on providing sustainable and cost-effective bio-based solutions for the life sciences, nutrition, and healthcare sectors.